Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2022-05-12 00:00:00 ET · period of report 2022-05-11 · accession 0001209191-22-028702 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-12 | 2022-05-11 | TVTX | ASELAGE STEVE | Dir | S - Sale | $21.92 | -2,575 | 146.9K | -2% | -$56.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-11 | S | D | 2,575 | $21.92 | 146,919 | D | — | — |